| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intellectual Disability | 29 | 2024 | 1047 | 4.790 |
Why?
|
| Phenotype | 40 | 2025 | 4313 | 2.460 |
Why?
|
| Abnormalities, Multiple | 10 | 2025 | 966 | 2.290 |
Why?
|
| Neurodevelopmental Disorders | 16 | 2024 | 523 | 2.010 |
Why?
|
| Hand Deformities, Congenital | 4 | 2022 | 95 | 1.510 |
Why?
|
| Microcephaly | 4 | 2022 | 343 | 1.490 |
Why?
|
| Mutation | 26 | 2024 | 5933 | 1.360 |
Why?
|
| Autism Spectrum Disorder | 5 | 2024 | 420 | 1.340 |
Why?
|
| Mutation, Missense | 14 | 2025 | 889 | 1.300 |
Why?
|
| Face | 4 | 2021 | 186 | 1.120 |
Why?
|
| Growth Disorders | 4 | 2022 | 185 | 1.060 |
Why?
|
| Cryptorchidism | 3 | 2022 | 38 | 0.990 |
Why?
|
| Nervous System Malformations | 3 | 2022 | 119 | 0.970 |
Why?
|
| Hydrocephalus | 2 | 2019 | 277 | 0.940 |
Why?
|
| Lysine-tRNA Ligase | 2 | 2023 | 5 | 0.920 |
Why?
|
| Blepharophimosis | 2 | 2024 | 25 | 0.880 |
Why?
|
| Chromosome Deletion | 4 | 2024 | 642 | 0.880 |
Why?
|
| Biomarkers | 3 | 2025 | 3149 | 0.860 |
Why?
|
| Neural Stem Cells | 1 | 2025 | 130 | 0.850 |
Why?
|
| Craniofacial Abnormalities | 6 | 2024 | 252 | 0.800 |
Why?
|
| Tetralogy of Fallot | 2 | 2022 | 173 | 0.760 |
Why?
|
| Child, Preschool | 32 | 2025 | 14375 | 0.750 |
Why?
|
| Intestinal Atresia | 1 | 2022 | 20 | 0.750 |
Why?
|
| Heart Defects, Congenital | 5 | 2024 | 1840 | 0.740 |
Why?
|
| Epilepsy | 7 | 2024 | 846 | 0.740 |
Why?
|
| Developmental Disabilities | 7 | 2024 | 718 | 0.720 |
Why?
|
| Hypotrichosis | 2 | 2024 | 8 | 0.720 |
Why?
|
| Facies | 7 | 2024 | 156 | 0.720 |
Why?
|
| DNA Helicases | 2 | 2022 | 229 | 0.720 |
Why?
|
| Malformations of Cortical Development | 2 | 2019 | 54 | 0.710 |
Why?
|
| Losartan | 1 | 2020 | 34 | 0.680 |
Why?
|
| Transcription Factors | 7 | 2025 | 2357 | 0.680 |
Why?
|
| Humans | 80 | 2025 | 126134 | 0.670 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 56 | 0.660 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2022 | 205 | 0.660 |
Why?
|
| Multiple Sulfatase Deficiency Disease | 1 | 2020 | 15 | 0.660 |
Why?
|
| Computational Biology | 1 | 2025 | 840 | 0.660 |
Why?
|
| Sulfatases | 1 | 2020 | 43 | 0.650 |
Why?
|
| Microfilament Proteins | 1 | 2022 | 264 | 0.650 |
Why?
|
| Comparative Genomic Hybridization | 5 | 2016 | 561 | 0.650 |
Why?
|
| Receptor, Notch3 | 1 | 2020 | 11 | 0.650 |
Why?
|
| Meningocele | 1 | 2020 | 17 | 0.640 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2024 | 130 | 0.630 |
Why?
|
| DNA Methylation | 7 | 2025 | 1036 | 0.630 |
Why?
|
| Adolescent | 27 | 2025 | 19986 | 0.620 |
Why?
|
| Cyclin D2 | 1 | 2019 | 14 | 0.620 |
Why?
|
| Pseudogenes | 1 | 2019 | 50 | 0.610 |
Why?
|
| Polydactyly | 1 | 2019 | 18 | 0.610 |
Why?
|
| Wolman Disease | 1 | 2019 | 7 | 0.600 |
Why?
|
| Sterol Esterase | 1 | 2019 | 19 | 0.600 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2019 | 96 | 0.590 |
Why?
|
| Micrognathism | 1 | 2019 | 65 | 0.580 |
Why?
|
| Male | 46 | 2025 | 62225 | 0.580 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2022 | 79 | 0.570 |
Why?
|
| Hematologic Diseases | 2 | 2021 | 73 | 0.570 |
Why?
|
| Child | 35 | 2024 | 25112 | 0.560 |
Why?
|
| Codon, Nonsense | 2 | 2020 | 140 | 0.560 |
Why?
|
| Neck | 1 | 2019 | 141 | 0.560 |
Why?
|
| Vestibular Diseases | 2 | 2021 | 64 | 0.550 |
Why?
|
| Lipoblastoma | 1 | 2017 | 6 | 0.550 |
Why?
|
| Dystonin | 1 | 2017 | 1 | 0.550 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2017 | 42 | 0.540 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2020 | 250 | 0.540 |
Why?
|
| Nuclear Proteins | 3 | 2024 | 1220 | 0.540 |
Why?
|
| Female | 46 | 2025 | 68037 | 0.540 |
Why?
|
| Diet, Ketogenic | 1 | 2017 | 24 | 0.540 |
Why?
|
| Fingers | 1 | 2017 | 61 | 0.530 |
Why?
|
| Rett Syndrome | 2 | 2020 | 217 | 0.520 |
Why?
|
| Membrane Glycoproteins | 1 | 2019 | 415 | 0.520 |
Why?
|
| Monocarboxylic Acid Transporters | 3 | 2022 | 34 | 0.520 |
Why?
|
| Vascular Malformations | 2 | 2022 | 107 | 0.510 |
Why?
|
| Limb Deformities, Congenital | 1 | 2017 | 109 | 0.510 |
Why?
|
| Symporters | 3 | 2022 | 72 | 0.500 |
Why?
|
| Gait | 1 | 2017 | 142 | 0.500 |
Why?
|
| Genetic Association Studies | 8 | 2024 | 808 | 0.500 |
Why?
|
| DNA-Binding Proteins | 5 | 2022 | 1901 | 0.490 |
Why?
|
| Sleep Wake Disorders | 1 | 2018 | 188 | 0.480 |
Why?
|
| Skin Diseases | 1 | 2017 | 136 | 0.480 |
Why?
|
| Lower Extremity | 1 | 2017 | 180 | 0.470 |
Why?
|
| Retina | 1 | 2019 | 484 | 0.470 |
Why?
|
| Gene Expression | 1 | 2019 | 1489 | 0.440 |
Why?
|
| Homocystinuria | 1 | 2014 | 26 | 0.430 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2014 | 64 | 0.430 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 666 | 0.430 |
Why?
|
| Langer-Giedion Syndrome | 1 | 2013 | 3 | 0.430 |
Why?
|
| Muscle Spasticity | 1 | 2014 | 55 | 0.420 |
Why?
|
| Pedigree | 8 | 2025 | 1655 | 0.420 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2013 | 16 | 0.410 |
Why?
|
| Infant | 15 | 2022 | 12803 | 0.410 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 391 | 0.400 |
Why?
|
| Young Adult | 13 | 2022 | 9635 | 0.400 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 1 | 2012 | 7 | 0.390 |
Why?
|
| Translocation, Genetic | 2 | 2013 | 348 | 0.380 |
Why?
|
| Lipodystrophy | 1 | 2012 | 32 | 0.380 |
Why?
|
| DNA Copy Number Variations | 2 | 2025 | 1005 | 0.370 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2021 | 3260 | 0.370 |
Why?
|
| Organoids | 2 | 2024 | 282 | 0.350 |
Why?
|
| Liver | 1 | 2019 | 1761 | 0.350 |
Why?
|
| Chromosome Disorders | 2 | 2025 | 315 | 0.340 |
Why?
|
| Fibroblasts | 3 | 2019 | 825 | 0.330 |
Why?
|
| Osteochondrodysplasias | 2 | 2021 | 66 | 0.330 |
Why?
|
| Syndrome | 7 | 2022 | 1114 | 0.320 |
Why?
|
| Follow-Up Studies | 6 | 2022 | 5107 | 0.320 |
Why?
|
| Smad4 Protein | 2 | 2022 | 56 | 0.320 |
Why?
|
| Muscle Hypotonia | 2 | 2022 | 187 | 0.310 |
Why?
|
| Heterozygote | 4 | 2021 | 691 | 0.310 |
Why?
|
| Brain | 5 | 2024 | 3031 | 0.300 |
Why?
|
| Epigenesis, Genetic | 5 | 2025 | 712 | 0.290 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 3895 | 0.290 |
Why?
|
| Seizures | 3 | 2022 | 853 | 0.280 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2019 | 161 | 0.280 |
Why?
|
| Exons | 4 | 2020 | 758 | 0.280 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2021 | 402 | 0.270 |
Why?
|
| Infant, Newborn | 7 | 2021 | 8381 | 0.250 |
Why?
|
| Lung | 1 | 2014 | 1524 | 0.240 |
Why?
|
| Prognosis | 5 | 2021 | 4697 | 0.240 |
Why?
|
| Zebrafish | 3 | 2023 | 400 | 0.240 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2025 | 17 | 0.230 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2020 | 154 | 0.230 |
Why?
|
| Brain Diseases | 3 | 2024 | 280 | 0.220 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2025 | 107 | 0.220 |
Why?
|
| Foot Deformities, Congenital | 2 | 2024 | 16 | 0.220 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2024 | 20 | 0.220 |
Why?
|
| Autophagosomes | 1 | 2024 | 27 | 0.220 |
Why?
|
| Contracture | 1 | 2024 | 27 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2024 | 109 | 0.210 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2024 | 22 | 0.210 |
Why?
|
| Gene Deletion | 2 | 2025 | 769 | 0.210 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2023 | 26 | 0.210 |
Why?
|
| Agammaglobulinemia | 1 | 2023 | 43 | 0.200 |
Why?
|
| Neurogenesis | 1 | 2025 | 206 | 0.200 |
Why?
|
| Serine | 1 | 2024 | 161 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2020 | 3593 | 0.200 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2024 | 156 | 0.200 |
Why?
|
| RNA Helicases | 2 | 2022 | 73 | 0.190 |
Why?
|
| Haploinsufficiency | 5 | 2024 | 264 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 4 | 2024 | 1097 | 0.190 |
Why?
|
| Lysosomes | 1 | 2024 | 250 | 0.190 |
Why?
|
| Landau-Kleffner Syndrome | 1 | 2022 | 7 | 0.190 |
Why?
|
| Repressor Proteins | 2 | 2024 | 765 | 0.190 |
Why?
|
| Genotype | 4 | 2022 | 2604 | 0.190 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 317 | 0.190 |
Why?
|
| Chromosome Aberrations | 2 | 2016 | 569 | 0.180 |
Why?
|
| Migraine with Aura | 1 | 2022 | 15 | 0.180 |
Why?
|
| Triiodothyronine | 1 | 2022 | 54 | 0.180 |
Why?
|
| Forkhead Transcription Factors | 1 | 2024 | 364 | 0.180 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2022 | 63 | 0.180 |
Why?
|
| Adult | 10 | 2022 | 30314 | 0.180 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 209 | 0.180 |
Why?
|
| Neural Crest | 1 | 2022 | 53 | 0.180 |
Why?
|
| Organisms, Genetically Modified | 1 | 2021 | 11 | 0.180 |
Why?
|
| Fused Kidney | 1 | 2021 | 3 | 0.180 |
Why?
|
| Eye Abnormalities | 1 | 2022 | 101 | 0.180 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2021 | 37 | 0.180 |
Why?
|
| Muscular Atrophy | 1 | 2022 | 72 | 0.180 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2021 | 22 | 0.170 |
Why?
|
| Autistic Disorder | 2 | 2023 | 362 | 0.170 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2023 | 271 | 0.170 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 2588 | 0.170 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2020 | 16 | 0.170 |
Why?
|
| Histone Acetyltransferases | 1 | 2021 | 224 | 0.170 |
Why?
|
| Myoclonic Epilepsies, Progressive | 1 | 2020 | 13 | 0.170 |
Why?
|
| Cytosol | 1 | 2021 | 139 | 0.170 |
Why?
|
| Sequence Deletion | 2 | 2014 | 510 | 0.170 |
Why?
|
| Rubinstein-Taybi Syndrome | 1 | 2020 | 16 | 0.170 |
Why?
|
| Isoenzymes | 1 | 2021 | 209 | 0.170 |
Why?
|
| Nicotinamide-Nucleotide Adenylyltransferase | 1 | 2020 | 14 | 0.170 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2020 | 49 | 0.170 |
Why?
|
| Inositol | 1 | 2020 | 14 | 0.170 |
Why?
|
| Agenesis of Corpus Callosum | 2 | 2022 | 44 | 0.170 |
Why?
|
| Transcription Factors, TFII | 1 | 2020 | 7 | 0.170 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2020 | 34 | 0.160 |
Why?
|
| RNA-Binding Proteins | 2 | 2021 | 537 | 0.160 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2020 | 33 | 0.160 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2020 | 47 | 0.160 |
Why?
|
| Adenosine Triphosphatases | 1 | 2021 | 193 | 0.160 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2020 | 31 | 0.160 |
Why?
|
| Hippocampus | 1 | 2025 | 775 | 0.160 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 151 | 0.160 |
Why?
|
| Williams Syndrome | 1 | 2020 | 41 | 0.160 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2021 | 138 | 0.160 |
Why?
|
| Language Development Disorders | 1 | 2021 | 177 | 0.160 |
Why?
|
| Cohort Studies | 4 | 2021 | 4894 | 0.160 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2020 | 78 | 0.160 |
Why?
|
| Genetics, Population | 1 | 2020 | 190 | 0.160 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2019 | 42 | 0.150 |
Why?
|
| Arthrogryposis | 1 | 2019 | 36 | 0.150 |
Why?
|
| Muscular Diseases | 1 | 2020 | 117 | 0.150 |
Why?
|
| Spine | 1 | 2020 | 136 | 0.150 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2019 | 74 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2020 | 146 | 0.150 |
Why?
|
| Homozygote | 1 | 2021 | 541 | 0.150 |
Why?
|
| Adaptor Protein Complex sigma Subunits | 1 | 2018 | 2 | 0.150 |
Why?
|
| Spasms, Infantile | 1 | 2020 | 165 | 0.150 |
Why?
|
| Folic Acid Deficiency | 1 | 2018 | 47 | 0.150 |
Why?
|
| Italy | 1 | 2018 | 133 | 0.140 |
Why?
|
| Hospitals, University | 1 | 2018 | 102 | 0.140 |
Why?
|
| Survival Rate | 2 | 2020 | 2055 | 0.140 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 2926 | 0.140 |
Why?
|
| Pupil Disorders | 1 | 2017 | 12 | 0.140 |
Why?
|
| Congenital Abnormalities | 1 | 2021 | 300 | 0.140 |
Why?
|
| Sex Distribution | 1 | 2018 | 306 | 0.140 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 418 | 0.140 |
Why?
|
| Age Distribution | 1 | 2018 | 415 | 0.140 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2017 | 39 | 0.130 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2019 | 242 | 0.130 |
Why?
|
| Age of Onset | 2 | 2019 | 609 | 0.130 |
Why?
|
| Gain of Function Mutation | 1 | 2017 | 99 | 0.130 |
Why?
|
| Mice | 5 | 2025 | 17619 | 0.130 |
Why?
|
| Cerebellum | 1 | 2020 | 415 | 0.130 |
Why?
|
| Analysis of Variance | 1 | 2018 | 950 | 0.130 |
Why?
|
| Cytogenetic Analysis | 2 | 2014 | 79 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2020 | 1385 | 0.130 |
Why?
|
| Alleles | 1 | 2021 | 1611 | 0.130 |
Why?
|
| Skin | 1 | 2019 | 516 | 0.120 |
Why?
|
| Polymicrogyria | 1 | 2016 | 2 | 0.120 |
Why?
|
| Mitochondria | 1 | 2021 | 722 | 0.120 |
Why?
|
| Pain | 1 | 2018 | 429 | 0.120 |
Why?
|
| Animals | 7 | 2025 | 33230 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2017 | 352 | 0.110 |
Why?
|
| Disease Progression | 1 | 2021 | 2110 | 0.110 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2014 | 11 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 329 | 0.110 |
Why?
|
| Wolf-Hirschhorn Syndrome | 1 | 2013 | 8 | 0.110 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2015 | 219 | 0.110 |
Why?
|
| Metabolomics | 1 | 2017 | 457 | 0.100 |
Why?
|
| Chromosome Banding | 1 | 2013 | 136 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2013 | 55 | 0.100 |
Why?
|
| Chromosome Breakage | 1 | 2014 | 158 | 0.100 |
Why?
|
| Comorbidity | 1 | 2018 | 1525 | 0.100 |
Why?
|
| Case-Control Studies | 4 | 2021 | 3307 | 0.100 |
Why?
|
| Deafness | 2 | 2024 | 82 | 0.100 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2014 | 40 | 0.100 |
Why?
|
| Hyperplasia | 1 | 2013 | 188 | 0.100 |
Why?
|
| CpG Islands | 2 | 2025 | 333 | 0.100 |
Why?
|
| Buttocks | 1 | 2012 | 5 | 0.100 |
Why?
|
| Psychotic Disorders | 1 | 2014 | 150 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2020 | 854 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2017 | 761 | 0.100 |
Why?
|
| Hypoglycemia | 1 | 2014 | 176 | 0.090 |
Why?
|
| Chromosome Duplication | 2 | 2025 | 146 | 0.090 |
Why?
|
| Nephrosis | 1 | 2012 | 6 | 0.090 |
Why?
|
| Thigh | 1 | 2012 | 50 | 0.090 |
Why?
|
| Hypoparathyroidism | 1 | 2012 | 11 | 0.090 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2012 | 48 | 0.090 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2012 | 64 | 0.090 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 753 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2012 | 66 | 0.090 |
Why?
|
| Fibrosis | 1 | 2013 | 394 | 0.090 |
Why?
|
| Incontinentia Pigmenti | 1 | 2011 | 16 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2906 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 2752 | 0.090 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein U | 2 | 2022 | 8 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2011 | 26 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 3658 | 0.090 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2012 | 141 | 0.090 |
Why?
|
| Incidence | 1 | 2018 | 3193 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2011 | 224 | 0.080 |
Why?
|
| Chromosomes, Human, X | 1 | 2011 | 151 | 0.080 |
Why?
|
| International Agencies | 2 | 2020 | 29 | 0.080 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2012 | 179 | 0.080 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2011 | 124 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 1218 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2022 | 16831 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2018 | 3422 | 0.080 |
Why?
|
| Gene Rearrangement | 1 | 2011 | 322 | 0.080 |
Why?
|
| Homeodomain Proteins | 2 | 2024 | 540 | 0.070 |
Why?
|
| Mitochondrial Proteins | 2 | 2023 | 272 | 0.070 |
Why?
|
| Middle Aged | 4 | 2022 | 27402 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 6582 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2014 | 1521 | 0.070 |
Why?
|
| Aged | 3 | 2022 | 20078 | 0.070 |
Why?
|
| Skin Abnormalities | 2 | 2020 | 35 | 0.060 |
Why?
|
| Electroencephalography | 2 | 2022 | 845 | 0.060 |
Why?
|
| Histocompatibility Antigens | 1 | 2024 | 15 | 0.060 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2024 | 66 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2024 | 111 | 0.050 |
Why?
|
| Prosencephalon | 1 | 2024 | 36 | 0.050 |
Why?
|
| Molecular Imaging | 1 | 2024 | 61 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2025 | 361 | 0.050 |
Why?
|
| United States | 1 | 2019 | 11187 | 0.050 |
Why?
|
| POU Domain Factors | 1 | 2023 | 8 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2024 | 351 | 0.050 |
Why?
|
| DNA, Intergenic | 1 | 2022 | 19 | 0.050 |
Why?
|
| RNA Recognition Motif Proteins | 1 | 2022 | 18 | 0.050 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2022 | 28 | 0.050 |
Why?
|
| p120 GTPase Activating Protein | 1 | 2022 | 5 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2025 | 676 | 0.050 |
Why?
|
| Gene Duplication | 1 | 2023 | 364 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2022 | 61 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2023 | 232 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2024 | 354 | 0.040 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2021 | 24 | 0.040 |
Why?
|
| Pregnancy | 1 | 2014 | 7395 | 0.040 |
Why?
|
| Syringomyelia | 1 | 2020 | 15 | 0.040 |
Why?
|
| Protein Stability | 1 | 2021 | 161 | 0.040 |
Why?
|
| CCCTC-Binding Factor | 1 | 2020 | 18 | 0.040 |
Why?
|
| KCNQ3 Potassium Channel | 1 | 2020 | 17 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 2021 | 159 | 0.040 |
Why?
|
| Epileptic Syndromes | 1 | 2020 | 36 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2024 | 4472 | 0.040 |
Why?
|
| NAD | 1 | 2020 | 50 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2020 | 19 | 0.040 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2020 | 14 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2020 | 75 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2020 | 192 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2024 | 485 | 0.040 |
Why?
|
| Retinal Degeneration | 1 | 2020 | 101 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2021 | 739 | 0.040 |
Why?
|
| Mitosis | 1 | 2019 | 191 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 780 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 200 | 0.040 |
Why?
|
| Proteins | 1 | 2024 | 1020 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2019 | 231 | 0.040 |
Why?
|
| Urogenital Abnormalities | 1 | 2020 | 160 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2023 | 1381 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2019 | 325 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2021 | 1067 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2019 | 690 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2013 | 1823 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2021 | 686 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2024 | 12393 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 2877 | 0.030 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2020 | 249 | 0.030 |
Why?
|
| Family | 1 | 2020 | 576 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 770 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 2555 | 0.030 |
Why?
|
| DNA | 1 | 2022 | 1430 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1852 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2024 | 3716 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2015 | 191 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 911 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 156 | 0.030 |
Why?
|
| Quality of Life | 1 | 2024 | 2014 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2012 | 115 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1783 | 0.020 |
Why?
|
| Joint Instability | 1 | 2012 | 57 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 1 | 2012 | 41 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2011 | 56 | 0.020 |
Why?
|
| Monosomy | 1 | 2011 | 25 | 0.020 |
Why?
|
| DiGeorge Syndrome | 1 | 2012 | 80 | 0.020 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2011 | 38 | 0.020 |
Why?
|
| Trisomy | 1 | 2011 | 107 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4433 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 566 | 0.020 |
Why?
|
| Histones | 1 | 2011 | 507 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2011 | 2552 | 0.010 |
Why?
|
| Obesity | 1 | 2013 | 2328 | 0.010 |
Why?
|